NantKwest, Inc. | License Agreements | Business Contracts

Second Amendment to Facility License Agreement, effective as of May 1, 2022, by and between NantWorks, LLC, the Licensor, and ImmunityBio, Inc., the Licensee (Filed With SEC on August 8, 2022)

Exclusive License Agreement, dated January 1, 2020, by and between ImmunityBio, Inc. and GlobeImmune, Inc (Filed With SEC on January 19, 2021)

Exclusive License Agreement, dated February 16, 2016, by and between NantBioScience, Inc. and Etubics Corporation (Filed With SEC on January 19, 2021)

Exclusive License Agreement, dated August 7, 2020, by and between ImmunityBio, Inc. and iosBio Ltd (Filed With SEC on January 19, 2021)

First Amendment to Facility License Agreement by and between NantWorks, LLC and NantKwest, Inc., dated September 14, 2020 (Filed With SEC on November 9, 2020)

NantKwest, Inc. (75) | License Agreements (5)